Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Alzheimer's Disease

  Free Subscription


2 Alzheimer Dis Assoc Disord
2 Alzheimers Dement
1 Biol Psychiatry
1 BMC Geriatr
1 Brain
1 Brain Res
2 Curr Alzheimer Res
1 Exp Neurol
9 J Alzheimers Dis
1 J Neural Transm (Vienna)
1 J Neurol Neurosurg Psychiatry
1 Nat Rev Neurol
3 Neurobiol Aging
1 Neurobiol Dis
1 Neurology
1 Neuropsychology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Alzheimer Dis Assoc Disord

  1. AL-THANI HF, Ahmad MN, Younes S, Zayed H, et al
    Genetic Variants Associated With Alzheimer Disease in the 22 Arab Countries: A Systematic Review.
    Alzheimer Dis Assoc Disord. 2021 Mar 23. pii: 00002093-900000000-99240.
    PubMed         Abstract available

  2. ERYILMAZ IE, Bakar M, Egeli U, Cecener G, et al
    Evaluation of the Clinical Features Accompanied by the Gene Mutations: The 2 Novel PSEN1 Variants in a Turkish Early-onset Alzheimer Disease Cohort.
    Alzheimer Dis Assoc Disord. 2021 Mar 24. pii: 00002093-900000000-99239.
    PubMed         Abstract available

    Alzheimers Dement

  3. 2021 Alzheimer's disease facts and figures.
    Alzheimers Dement. 2021 Mar 23. doi: 10.1002/alz.12328.
    PubMed         Abstract available

  4. AKHTER-KHAN SC, Tao Q, Ang TFA, Itchapurapu IS, et al
    Associations of loneliness with risk of Alzheimer's disease dementia in the Framingham Heart Study.
    Alzheimers Dement. 2021 Mar 24. doi: 10.1002/alz.12327.
    PubMed         Abstract available

    Biol Psychiatry

    Good News for Dementia Prevention: Multiple Behavioral Features Are Associated With Markers of Brain Pathology in the Preclinical Phase of Sporadic and Autosomal Dominant Alzheimer's Disease.
    Biol Psychiatry. 2021;89:739-741.

    BMC Geriatr

  6. RAJAMAKI B, Hartikainen S, Tolppanen AM
    The effect of comorbidities on survival in persons with Alzheimer's disease: a matched cohort study.
    BMC Geriatr. 2021;21:173.
    PubMed         Abstract available


  7. YAP SY, Frias B, Wren MC, Scholl M, et al
    Discriminatory ability of next-generation tau PET tracers for Alzheimer's disease.
    Brain. 2021 Mar 20. pii: 6179104. doi: 10.1093.
    PubMed         Abstract available

    Brain Res

  8. PAIROJANA T, Phasuk S, Suresh P, Huang SP, et al
    Age and Gender Differences for the Behavioral Phenotypes of 3xTg Alzheimer's Disease mice.
    Brain Res. 2021 Mar 19:147437. doi: 10.1016/j.brainres.2021.147437.
    PubMed         Abstract available

    Curr Alzheimer Res

  9. YEE A, Tsui NBY, Kwan RYC, Leung AYM, et al
    Apolipoprotein E Gene Revisited: Contribution of Rare Variants to Alzheimer's Disease Susceptibility in Southern Chinese.
    Curr Alzheimer Res. 2021 Mar 24. pii: CAR-EPUB-115024.
    PubMed         Abstract available

  10. VESKOVIC A, Nakarada D, Pavicevic A, Prokic B, et al
    In vivo/Ex Vivo EPR Investigation of the Brain Redox Status and Blood--Brain Barrier Integrity in the 5xFAD Mouse Model of Alzheimer's Disease.
    Curr Alzheimer Res. 2021 Mar 24. pii: CAR-EPUB-115029.
    PubMed         Abstract available

    Exp Neurol

  11. NEVES AF, Camargo C, Premer C, Hare JM, et al
    Intravenous administration of mesenchymal stem cells reduces Tau phosphorylation and inflammation in the 3xTg-AD mouse model of Alzheimer's disease.
    Exp Neurol. 2021 Mar 20:113706. doi: 10.1016/j.expneurol.2021.113706.
    PubMed         Abstract available

    J Alzheimers Dis

  12. NI R, Rojdner J, Voytenko L, Dyrks T, et al
    In vitro Characterization of the Regional Binding Distribution of Amyloid PET Tracer Florbetaben and the Glia Tracers Deprenyl and PK1195 in Autopsy Alzheimer's Brain Tissue.
    J Alzheimers Dis. 2021 Mar 16. pii: JAD201344. doi: 10.3233/JAD-201344.
    PubMed         Abstract available

  13. ARAYA J, Bello F, Shivashankar G, Neira D, et al
    Retinal Ganglion Cells Functional Changes in a Mouse Model of Alzheimer's Disease Are Linked with Neurotransmitter Alterations.
    J Alzheimers Dis. 2021 Mar 13. pii: JAD201195. doi: 10.3233/JAD-201195.
    PubMed         Abstract available

  14. YANG J, Jia L, Li Y, Qiu Q, et al
    Fluid Biomarkers in Clinical Trials for Alzheimer's Disease: Current and Future Application.
    J Alzheimers Dis. 2021 Mar 13. pii: JAD201068. doi: 10.3233/JAD-201068.
    PubMed         Abstract available

  15. MIRANDA A, Montiel E, Ulrich H, Paz C, et al
    Selective Secretase Targeting for Alzheimer's Disease Therapy.
    J Alzheimers Dis. 2021 Mar 13. pii: JAD201027. doi: 10.3233/JAD-201027.
    PubMed         Abstract available

  16. FONSECA LM, Mattar GP, Haddad GG, Ekaterina B, et al
    Neuropsychiatric Symptoms of Alzheimer's Disease in Down Syndrome and Its Impact on Caregiver Distress.
    J Alzheimers Dis. 2021 Mar 16. pii: JAD201009. doi: 10.3233/JAD-201009.
    PubMed         Abstract available

  17. MA YH, Wang YY, Tan L, Xu W, et al
    Social Networks and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
    J Alzheimers Dis. 2021 Mar 15. pii: JAD201426. doi: 10.3233/JAD-201426.
    PubMed         Abstract available

  18. ASTROM DO, Adolfsson R, Segersson D, Forsberg B, et al
    Local Contrasts in Concentration of Ambient Particulate Air Pollution (PM2.5) and Incidence of Alzheimer's Disease and Dementia: Results from the Betula Cohort in Northern Sweden.
    J Alzheimers Dis. 2021 Mar 18. pii: JAD201538. doi: 10.3233/JAD-201538.
    PubMed         Abstract available

  19. GAUDREAULT R, Herve V, van de Ven TGM, Mousseau N, et al
    Polyphenol-Peptide Interactions in Mitigation of Alzheimer's Disease: Role of Biosurface-Induced Aggregation.
    J Alzheimers Dis. 2021 Mar 15. pii: JAD201549. doi: 10.3233/JAD-201549.
    PubMed         Abstract available

  20. Quantifying and Describing the Natural History and Costs of Alzheimer's Disease and Effects of Hypothetical Interventions.
    J Alzheimers Dis. 2021 Mar 16. pii: JAD219002. doi: 10.3233/JAD-219002.

    J Neural Transm (Vienna)

    Ted Sourkes, Moussa Youdim and I.
    J Neural Transm (Vienna). 2020;127:119-123.

    J Neurol Neurosurg Psychiatry

  22. KOH W, Lim L, Low A, Wong B, et al
    Development and validation of a brief visual based cognitive screening tool for dementia: the Visual Cognitive Assessment Test short-form (VCAT-S).
    J Neurol Neurosurg Psychiatry. 2020;91:1122-1123.

    Nat Rev Neurol

    Distinct microglial profiles associated with amyloid and tau pathology in Alzheimer disease.
    Nat Rev Neurol. 2021 Mar 9. pii: 10.1038/s41582-021-00482.

    Neurobiol Aging

  24. ALLISON SL, Jonaitis EM, Koscik RL, Hermann BP, et al
    Neurodegeneration, Alzheimer's disease biomarkers, and longitudinal verbal learning and memory performance in late middle age.
    Neurobiol Aging. 2021;102:151-160.
    PubMed         Abstract available

  25. KARA F, Belloy ME, Voncken R, Sarwari Z, et al
    Long-term ovarian hormone deprivation alters functional connectivity, brain neurochemical profile and white matter integrity in the Tg2576 amyloid mouse model of Alzheimer's disease.
    Neurobiol Aging. 2021;102:139-150.
    PubMed         Abstract available

  26. RUBINSKI A, Tosun D, Franzmeier N, Neitzel J, et al
    Lower cerebral perfusion is associated with tau-PET in the entorhinal cortex across the Alzheimer's continuum.
    Neurobiol Aging. 2021;102:111-118.
    PubMed         Abstract available

    Neurobiol Dis

  27. JIANG N, Cupolillo D, Grosjean N, Muller E, et al
    Impaired plasticity of intrinsic excitability in the dentate gyrus alters spike transfer in a mouse model of Alzheimer's disease.
    Neurobiol Dis. 2021 Mar 22:105345. doi: 10.1016/j.nbd.2021.105345.
    PubMed         Abstract available


  28. GOTTESMAN RF, Hamilton R
    Recruiting Diverse Populations in Clinical Trials: How Do We Overcome Selection Bias?
    Neurology. 2021;96:509-510.


  29. COLLIN BG, Raju D, Katsikas S
    The cognitive effects of anticholinergic drugs on apolipoprotein epsilon4 carriers and noncarriers in the Wisconsin Registry for Alzheimer's Prevention study.
    Neuropsychology. 2021;35:220-231.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.